Results for tag: "Metered Dose Inhaler"

The Metered Dose Inhaler (MDI) market is a subset of the larger Inhalers and Nebulisers market. MDIs are a type of inhaler that dispenses a measured dose of medication in aerosol form, which is then inhaled into the lungs. MDIs are the most commonly used type of inhaler, and are used to treat a variety of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). MDIs are typically small, portable, and easy to use, making them a popular choice for patients. MDIs are typically composed of a pressurized canister containing medication, a metering valve, and an actuator. The canister is filled with a propellant, which is used to expel the medication from the canister. The metering valve is used to control the amount of medication that is released, while the actuator is used to deliver the medication to the patient. The MDI market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck, and Novartis. Show Less Read more